Sean L. Cunningham
Sean joined GTCR in 2001 and is currently a Managing Director of the firm. He was previously a Consultant with The Boston Consulting Group. Sean holds an MBA from the Wharton School at the University of Pennsylvania as well as AB and BE degrees in engineering sciences from Dartmouth College.
Sean currently is a Director of Albany Molecular Research, Ceba-Tech, Cedar Gate Technologies, Correct Care Solutions, Maravai LifeSciences, Regatta, Riverchase Dermatology, Sotera and Transaction Data Systems. He was instrumental in GTCR’s past investments in Cole-Parmer, Cord Blood Registry, Devicor Medical Products, Graceway Pharmaceuticals and Ovation Pharmaceuticals.